Drug Type Small molecule drug |
Synonyms (S)-3-(Aminomethyl)-[1,3]dioxolo[4',5':5,6]benzo[1,2-c][1,2]oxaborol-1(3H)-ol hydrochloride, DS 86760016 |
Target |
Action inhibitors |
Mechanism LeuRS inhibitors(Leucyl-tRNA synthetase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC9H11BClNO4 |
InChIKeyFYHCZFHPLJMBAX-OGFXRTJISA-N |
CAS Registry1853176-89-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pseudomonas Infections | Preclinical | India | 27 May 2019 |